脑再生科技（RGC）今日盘中表现强劲，股价大涨41.94%，引发市场广泛关注。该股在早盘低开后迅速反弹，涨幅一度超过23%并触发熔断机制。
脑再生科技是一家专注于中医药治疗神经认知障碍和退化的生物科技公司，主要研究注意力缺陷与多动障碍（ADHD）和自闭症谱系障碍（ASD）的治疗方法。近期，脑机接口概念股集体爆发，成为推动脑再生科技股价上涨的重要因素。据报道，马斯克旗下的Neuralink公司估值已达90亿美元，并计划在未来一年内为20-30名患者植入脑机芯片。这一消息激发了投资者对脑机接口技术前景的乐观预期。
值得注意的是，脑再生科技今年以来的股价表现极为亮眼，截至6月18日，其股价已累计上涨超过599倍，市值达到385亿美元。然而，如此巨大的涨幅也伴随着较高的波动性。数据显示，该股在过去5个交易日内涨幅达51.43%，而在6月23日单日则下跌37.65%。投资者在关注该股投资机会的同时，也应当充分认识到其中蕴含的高风险。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.